Head-to-Head

Jupiter Neurosciences, Inc. Common Stock vs. Eli Lilly & Co.

JUNS

Jupiter Neurosciences, Inc. Common Stock

$4.82 -3.79%

VS LLY

Eli Lilly & Co.

$1189.41 -3.59%

Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

JUNSLLY
Market Cap $6.66 million $1.06 trillion
Revenue (TTM) — $79.67 billion
Net Income (TTM) — $26.71 billion

LLY leads on 1 of 1 size & scale factors.

Valuation

JUNSLLY
P/E Ratio — 39.93
Price / Book — 31.29
Price / Sales — 13.31

JUNS and LLY split the valuation factors evenly.

Profitability

JUNSLLY
Net Margin — 33.53%
Return on Equity — 78.84%

JUNS and LLY split the profitability factors evenly.

Dividend

JUNSLLY
Dividend Yield — 0.58%
Payout Ratio — 23.23

JUNS and LLY split the dividend factors evenly.

Risk & Sentiment

JUNSLLY
Short Interest 3.52% 1.29%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: JUNS overview, JUNS financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.